Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
157 hedge funds and large institutions have $1.99B invested in Immunomedics Inc in 2017 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 58 increasing their positions, 48 reducing their positions, and 28 closing their positions.
100% more call options, than puts
Call options by funds: $168M | Put options by funds: $84.2M
25% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 28
23% more capital invested
Capital invested by funds: $1.62B → $1.99B (+$370M)
21% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 48
5% more funds holding
Funds holding: 150 → 157 (+7)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$39.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$38.6M |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$20.8M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$20.1M |
| 5 |
State Street
Boston,
Massachusetts
|
+$19.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$40M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$20.7M |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$19.6M |
| 4 |
O
OrbiMed
New York
|
-$18.1M |
| 5 |
Renaissance Technologies
New York
|
-$14.2M |
IMMU Hedge Fund Activity: Q4 2017 in Review
157 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q4 2017, worth a combined $1.99B — up 23% from $1.62B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new IMMU positions and 28 closed out — a net gain of 7 holders — while 58 added to existing stakes and 48 trimmed.
The largest buyer was Millennium Management, adding an estimated $39.9M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $40M sold.
- 157 institutional investors held Immunomedics Inc (IMMU) as of Q4 2017, up from 150 in Q3 2017.
- Funds reported $1.99B of Immunomedics Inc stock for Q4 2017, up 23% quarter-over-quarter.
- 35 funds opened new Immunomedics Inc positions in Q4 2017 and 28 closed out, a net change of +7 holders.
- The largest Immunomedics Inc buyer in Q4 2017 was Millennium Management, an estimated $39.9M added.
- The largest Immunomedics Inc seller in Q4 2017 was EcoR1 Capital, an estimated $40M sold.
Based on aggregated 13F filings for Q4 2017.